Kidon, Mona (10339388800)Mona (10339388800)KidonBlanca-Lopez, Natalia (16835888500)Natalia (16835888500)Blanca-LopezGomes, Eva (7102464240)Eva (7102464240)GomesTerreehorst, Ingrid (55888235900)Ingrid (55888235900)TerreehorstTanno, Luciana (35575132500)Luciana (35575132500)TannoPonvert, Claude (56188020000)Claude (56188020000)PonvertChin, Chiang Wen (57200009116)Chiang Wen (57200009116)ChinCaubet, Jean Christoph (36460677400)Jean Christoph (36460677400)CaubetSoyer, Ozge (24483981200)Ozge (24483981200)SoyerMori, Francesca (58041318500)Francesca (58041318500)MoriBlanca, Miguel (56004093600)Miguel (56004093600)BlancaAtanaskovic-Markovic, Marina (6506020842)Marina (6506020842)Atanaskovic-Markovic2025-07-022025-07-022018https://doi.org/10.1111/pai.12915https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050808813&doi=10.1111%2fpai.12915&partnerID=40&md5=b8502f3492448994a292e532c318fcfehttps://remedy.med.bg.ac.rs/handle/123456789/12906Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used in the pediatric population as antipyretics/analgesics and anti-inflammatory medications. Hypersensitivity (HS) reactions to NSAID in this age group, while similar to adults, have unique diagnostic and management issues. Although slowly accumulating, published data in this age group are still relatively rare and lacking a unifying consensus. This work is a summary of current knowledge and consensus recommendations utilizing both published data and expert opinion from the European Network of Drug Allergy (ENDA) and the Drug Hypersensitivity interest group in the European Academy of Allergy and Clinical Immunology (EAACI). This position paper summarizes diagnostic and management guidelines for children and adolescents with NSAIDs hypersensitivity. © 2018 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.AdolescentChildDrug HypersensitivityEAACIENDANon Steroidal Anti Inflammatory DrugsNSAIDsPosition Paper